Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083516199> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W2083516199 endingPage "8" @default.
- W2083516199 startingPage "8" @default.
- W2083516199 abstract "The cysteinyl leukotrienes (cys-LTs), i.e. LTC4, LTD4 and LTE4, trigger contractile and inflammatory processes through the specific interaction with cell surface receptors belonging to the purine receptor cluster of the rhodopsin family of the G protein-coupled receptor (GPCR) genes. Cys-LTs have a clear role in pathophysiological conditions such as asthma, allergic rhinitis and other nasal allergies, and have been implicated in a number of inflammatory conditions including cardiovascular and gastrointestinal diseases. Pharmacological studies have identified two classes of cys-LT receptors (CysLT1 and CysLT2) based on their sensitivity to CysLT1 selective antagonists, albeit there is evidence for additional subtypes. Molecular cloning of the human CysLT1 and CysLT2 receptors has confirmed both their structure as putative seven transmembrane domain G protein-coupled receptors and most of the previous pharmacological characterization. The rank order of potency of agonist activation for the CysLT1 receptor is LTD4>LTC4>LTE4 and for the CysLT2 receptor is LTC4=LTD4>LTE4. The CysLT1 receptor is most highly expressed in spleen, peripheral blood leukocytes, interstitial lung macrophages and in airway smooth muscle. The CysLT2 receptor is mostly expressed in heart, adrenals, placenta, spleen, peripheral blood leukocytes and less strongly in the brain. Gene cloning of CysLT1 and CysLT2 receptors has renewed the attention on the cys-LTs field and will, hopefully, encourage future studies on the regulation of CysLT receptors expression and the dissection of their signalling pathways. Furthermore, the peculiar pattern of expression of the two receptor subtypes will promote the discovery of new functions for cys-LTs in physiological and pathological conditions. Only CysLT1 selective receptor antagonists have been described to date and are currently available for the treatment of asthma. Molecular cloning of different CysLT receptor subtypes will certainly foster the development of new selective antagonists based on molecular modelling studies." @default.
- W2083516199 created "2016-06-24" @default.
- W2083516199 creator A5064416054 @default.
- W2083516199 date "1995-01-01" @default.
- W2083516199 modified "2023-09-26" @default.
- W2083516199 title "Pharmacology of leukotriene antagonists and other anti-leukotriene drugs" @default.
- W2083516199 doi "https://doi.org/10.1016/1043-6618(95)86293-5" @default.
- W2083516199 hasPublicationYear "1995" @default.
- W2083516199 type Work @default.
- W2083516199 sameAs 2083516199 @default.
- W2083516199 citedByCount "0" @default.
- W2083516199 crossrefType "journal-article" @default.
- W2083516199 hasAuthorship W2083516199A5064416054 @default.
- W2083516199 hasConcept C126322002 @default.
- W2083516199 hasConcept C135285700 @default.
- W2083516199 hasConcept C170493617 @default.
- W2083516199 hasConcept C203014093 @default.
- W2083516199 hasConcept C2776885963 @default.
- W2083516199 hasConcept C2777242621 @default.
- W2083516199 hasConcept C2778938600 @default.
- W2083516199 hasConcept C71924100 @default.
- W2083516199 hasConcept C86803240 @default.
- W2083516199 hasConcept C98274493 @default.
- W2083516199 hasConceptScore W2083516199C126322002 @default.
- W2083516199 hasConceptScore W2083516199C135285700 @default.
- W2083516199 hasConceptScore W2083516199C170493617 @default.
- W2083516199 hasConceptScore W2083516199C203014093 @default.
- W2083516199 hasConceptScore W2083516199C2776885963 @default.
- W2083516199 hasConceptScore W2083516199C2777242621 @default.
- W2083516199 hasConceptScore W2083516199C2778938600 @default.
- W2083516199 hasConceptScore W2083516199C71924100 @default.
- W2083516199 hasConceptScore W2083516199C86803240 @default.
- W2083516199 hasConceptScore W2083516199C98274493 @default.
- W2083516199 hasLocation W20835161991 @default.
- W2083516199 hasOpenAccess W2083516199 @default.
- W2083516199 hasPrimaryLocation W20835161991 @default.
- W2083516199 hasRelatedWork W1796716201 @default.
- W2083516199 hasRelatedWork W1976548894 @default.
- W2083516199 hasRelatedWork W1979013132 @default.
- W2083516199 hasRelatedWork W2087997238 @default.
- W2083516199 hasRelatedWork W2106886135 @default.
- W2083516199 hasRelatedWork W2600082220 @default.
- W2083516199 hasRelatedWork W2766465375 @default.
- W2083516199 hasRelatedWork W2783220867 @default.
- W2083516199 hasRelatedWork W2784655325 @default.
- W2083516199 hasRelatedWork W4286856416 @default.
- W2083516199 hasVolume "31" @default.
- W2083516199 isParatext "false" @default.
- W2083516199 isRetracted "false" @default.
- W2083516199 magId "2083516199" @default.
- W2083516199 workType "article" @default.